Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-866,087 in Female Sexual Arousal Disorder
NCT00482664Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of CP-866087 in Sexual Arousal Disorder, sponsored by Pfizer. Started Jul 2007; status: completed.
02
Drugs
CP-866087
03
Conditions
Sexual Arousal Disorder
Beyond the preview
Go deeper on NCT00482664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482664.